OPTIMAL USAGE OF SACUBITRIL/VALSARTAN FOR HEART FAILURE TREATMENT IN CANADA POTENTIALLY REDUCES HOSPITALIZATIONS AND EARLY DISCHARGE RE-ADMISSIONS
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2017
has subject area
- 1102 Cardiorespiratory Medicine and Haematology (FoR)
- Cardiovascular System & Hematology (Science Metrix)
published in
- Canadian Journal of Cardiology Journal